Rispoval® RS+PI3 IntraNasal contains modified live PI3 virus, strain ts RLB103 and modified live BRSV, strain 375. For the active immunisation of MDA positive or negative calves from 9 days of age against BRSV and PI3 virus, to reduce the mean titre and duration of excretion of both viruses. POM-V
Rispoval® 4 contains attenuated BRSV strain 375 and PI3 virus strain ts RLB103 with inactivated, adjuvanted IBR virus strain Cooper and BVDV type 1 strains 5960 (cytopathic) and 6309 (non-cytopathic). For the active immunisation of cattle to reduce infection, clinical signs and respiratory disease caused by BRSV, IBR (BHV-1) virus and PI3 virus; and leucopenia and viraemia caused by the BVDV Type 1, cytopathic and non-cytopathic strains. POM-V
Tracherine™ contains live attenuated IBR virus strain ts RLB 106. For the active immunisation of calves and growing cattle to reduce viral shedding and clinical signs caused by BHV-1. POM-V
Rispoval® IBR-Marker Live contains attenuated gE negative BHV-1 strain Difivac. For the active immunisation of cattle to reduce the clinical signs of IBR, reduce virus shedding and to reduce BHV-1 associated abortions. POM-V
Rispoval® 3 contains modified live PI3 virus, strain RLB 103 and BRSV strain 375 with inactivated adjuvanted BVDV type 1, strains 5960 (cytopathic) and 6309 (non-cytopathic). For the active immunisation of calves to reduce virus excretion and clinical signs caused by PI3 virus, to reduce virus excretion caused by BRSV infection, and reduce virus excretion and severity of leucopenia induced by BVDV type 1 infection. POM-V
Imuresp™ RP contains live attenuated PI3 virus, strain ts RLB 103 and live attenuated IBR virus, strain ts RLB 106. For the active immunisation of calves and growing cattle to reduce the clinical signs and viral shedding associated with BHV-1 and to reduce PI3 viral shedding from infected animals. POM-V
Rispoval® Pasteurella contains Mannheimia (Pasteurella) haemolytica biotype A, serotype 1 strain NL1009, together with an oil-in-water adjuvant. For the active immunisation of cattle to reduce lesions and respiratory disease caused by Pasteurella haemolytica biotype A, serotype 1. POM-V
For information about side effects, precautions, warnings and contra-indications, please refer to the product packaging and package leaflet.
The material on this site is intended for UK professional keepers of animals, UK veterinary surgeons and SQPs only. By continuing to browse the site, you confirm that this describes you.
Alternatively you can call us on
0845 300 8034
- Costa Rica
- Czech Republic
- New Zealand
- South Africa
- South Korea
- United Kingdom
- United States
You are leaving the country website to access another site in the group.
Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.